TABLE 2.
BC | MB | NB | NF | NS | ON | PE | QC | SK | |
---|---|---|---|---|---|---|---|---|---|
AB | ns | ns | <0.001 | ns | ns | ns | ns | <0.001 | <0.001 |
BC | – | 0.002 | <0.001 | 0.022 | 0.024 | ns | ns | <0.001 | 0.032 |
MB | – | – | 0.013 | ns | ns | 0.001 | 0.002 | <0.001 | <0.001 |
NB | – | – | – | 0.001 | 0.001 | <0.001 | <0.001 | ns | <0.001 |
NF | – | – | – | – | 0.012 | ns | 0.023 | <0.001 | <0.001 |
NS | – | – | – | – | – | 0.013 | 0.026 | <0.001 | <0.001 |
ON | – | – | – | – | – | – | ns | <0.001 | ns |
PE | – | – | – | – | – | – | – | <0.001 | 0.031 |
QC | – | – | – | – | – | – | – | – | <0.001 |
This table is a companion table to Figure 2A. BC British Columbia; MB Manitoba; NB New Brunswick; NF Newfoundland and Labrador; ns No significant difference in the DDDs per prescription between the two provinces; NS Nova Scotia; ON Ontario; PE Prince Edward Island; QC Quebec; SK Saskatchewan